Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Director departure

GW PHARMACEUTICALS PLC (GWPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
05/17/2021 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
05/07/2021 4 Tovey Christopher J. (COO) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns: Disposed/sold 2,496 shares @ $0
Disposed/sold 52,560 options to buy @ $9.8117, valued at $515.7k
Disposed/sold 6,468 options to buy @ $0.0017, valued at $11
Disposed/sold 58,884 options to buy @ $9.6092, valued at $565.8k
Disposed/sold 119,340 options to buy @ $0.0017, valued at $202.9
Disposed/sold 17,904 options to buy @ $0.0017, valued at $30.4
Disposed/sold 42,048 options to buy @ $14.3342, valued at $602.7k
Disposed/sold 79,812 options to buy @ $0.0017, valued at $135.7
Disposed/sold 17,964 options to buy @ $0.0017, valued at $30.5
Disposed/sold 137,016 options to buy @ $0.0017, valued at $232.9
Disposed/sold 82,224 options to buy @ $0.0017, valued at $139.8
05/07/2021 4 Cline Darren S (U.S. Chief Commercial Officer) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns: Disposed/sold 5,556 shares @ $0
Disposed/sold 54,192 options to buy @ $15.3017, valued at $829.2k
Disposed/sold 22,068 options to buy @ $0.0017, valued at $37.5
Disposed/sold 98,040 options to buy @ $0.0017, valued at $166.7
Disposed/sold 106,320 options to buy @ $0.0017, valued at $180.7
Disposed/sold 177,180 options to buy @ $0.0017, valued at $301.2
Disposed/sold 46,896 options to buy @ $0.0017, valued at $79.7
Disposed/sold 75,024 options to buy @ $0.0017, valued at $127.5
05/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/07/2021 4 Snyder Douglas B. (Chief Legal Officer) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns: Disposed/sold 61,848 shares @ $0
Disposed/sold 82,956 options to buy @ $8.3767, valued at $694.9k
Disposed/sold 63,252 options to buy @ $9.6092, valued at $607.8k
Disposed/sold 46,644 options to buy @ $14.3342, valued at $668.6k
Disposed/sold 9,180 options to buy @ $0.0017, valued at $15.6
Disposed/sold 9,612 options to buy @ $0.0017, valued at $16.3
Disposed/sold 88,524 options to buy @ $0.0017, valued at $150.5
Disposed/sold 13,272 options to buy @ $0.0017, valued at $22.6
Disposed/sold 149,856 options to buy @ $0.0017, valued at $254.8
Disposed/sold 89,952 options to buy @ $0.0017, valued at $152.9
Disposed/sold 45,360 options to buy @ $0.0017, valued at $77.1
05/07/2021 4 Gover Justin D. (CEO) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns: Disposed/sold 222,773 shares @ $0
Disposed/sold 456,048 shares @ $0
Disposed/sold 1,867,308 shares @ $0
Disposed/sold 17,508 options to buy @ $0.0017, valued at $29.8
Disposed/sold 75,864 options to buy @ $10.605, valued at $804.5k
Disposed/sold 213,240 options to buy @ $3.72, valued at $793.3k
Disposed/sold 142,344 options to buy @ $9.8117, valued at $1.4M
Disposed/sold 147,624 options to buy @ $9.6092, valued at $1.4M
Disposed/sold 119,472 options to buy @ $14.3342, valued at $1.7M
Disposed/sold 30,936 options to buy @ $14.645, valued at $453.1k
Disposed/sold 22,440 options to buy @ $0.0017, valued at $38.1
05/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/07/2021 4 MACKEY CATHERINE J (Director) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns: Disposed/sold 10,536 shares @ $0
Disposed/sold 35,340 options to buy @ $11.1742, valued at $394.9k
Disposed/sold 16,548 options to buy @ $14.3342, valued at $237.2k
Disposed/sold 3,144 options to buy @ $0.0017, valued at $5.3
Disposed/sold 34,416 options to buy @ $0.0017, valued at $58.5
Disposed/sold 22,464 options to buy @ $0.0017, valued at $38.2
05/07/2021 4 Knappertz Volker (Chief Medical Officer) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns: Disposed/sold 92,412 shares @ $0
Disposed/sold 150,444 options to buy @ $8.6433, valued at $1.3M
Disposed/sold 55,536 options to buy @ $9.6092, valued at $533.7k
Disposed/sold 48,252 options to buy @ $14.3342, valued at $691.7k
Disposed/sold 12,156 options to buy @ $0.0017, valued at $20.7
Disposed/sold 8,436 options to buy @ $0.0017, valued at $14.3
Disposed/sold 91,584 options to buy @ $0.0017, valued at $155.7
Disposed/sold 13,728 options to buy @ $0.0017, valued at $23.3
Disposed/sold 155,028 options to buy @ $0.0017, valued at $263.5
Disposed/sold 93,024 options to buy @ $0.0017, valued at $158.1
Disposed/sold 47,808 options to buy @ $0.0017, valued at $81.3
05/07/2021 4 GUY GEOFFREY W DR (Executive Chairman) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns: Disposed/sold 4,781,521 shares @ $0
Disposed/sold 25,000 shares @ $0
Disposed/sold 103,925 shares @ $0
Disposed/sold 138,672 options to buy @ $8.3767, valued at $1.2M
Disposed/sold 15,336 options to buy @ $0.0017, valued at $26.1
Disposed/sold 107,352 options to buy @ $9.6092, valued at $1M
Disposed/sold 217,572 options to buy @ $0.0017, valued at $369.9
Disposed/sold 32,616 options to buy @ $0.0017, valued at $55.4
Disposed/sold 75,252 options to buy @ $14.3342, valued at $1.1M
Disposed/sold 142,824 options to buy @ $0.0017, valued at $242.8
Disposed/sold 32,112 options to buy @ $0.0017, valued at $54.6
05/07/2021 4 Secor Alicia (Director) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns: Disposed/sold 10,584 shares @ $0
Disposed/sold 35,340 options to buy @ $11.1742, valued at $394.9k
Disposed/sold 16,548 options to buy @ $14.3342, valued at $237.2k
Disposed/sold 3,144 options to buy @ $0.0017, valued at $5.3
Disposed/sold 34,416 options to buy @ $0.0017, valued at $58.5
Disposed/sold 22,464 options to buy @ $0.0017, valued at $38.2
05/07/2021 4 Giacobello Scott M. (CFO) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns: Disposed/sold 165,108 shares @ $0
Disposed/sold 67,164 options to buy @ $8.6433, valued at $580.5k
Disposed/sold 68,460 options to buy @ $9.6092, valued at $657.8k
Disposed/sold 44,184 options to buy @ $14.3342, valued at $633.3k
Disposed/sold 8,136 options to buy @ $0.0017, valued at $13.8
Disposed/sold 10,404 options to buy @ $0.0017, valued at $17.7
Disposed/sold 83,844 options to buy @ $0.0017, valued at $142.5
Disposed/sold 12,576 options to buy @ $0.0017, valued at $21.4
Disposed/sold 144,828 options to buy @ $0.0017, valued at $246.2
Disposed/sold 86,928 options to buy @ $0.0017, valued at $147.8
Disposed/sold 43,824 options to buy @ $0.0017, valued at $74.5
05/07/2021 4 Brown Cabot (Director) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns: Disposed/sold 7,200 shares @ $0
Disposed/sold 9,168 options to buy @ $0.0017, valued at $15.6
Disposed/sold 34,056 options to buy @ $5.6992, valued at $194.1k
Disposed/sold 18,636 options to buy @ $9.8117, valued at $182.9k
Disposed/sold 17,676 options to buy @ $11.1742, valued at $197.5k
Disposed/sold 16,548 options to buy @ $14.3342, valued at $237.2k
Disposed/sold 3,144 options to buy @ $0.0017, valued at $5.3
Disposed/sold 34,416 options to buy @ $0.0017, valued at $58.5
Disposed/sold 22,464 options to buy @ $0.0017, valued at $38.2
05/07/2021 4 Waldegrave William A. (Director) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns: Disposed/sold 35,340 options to buy @ $11.1742, valued at $394.9k
Disposed/sold 7,164 options to buy @ $0.0017, valued at $12.2
Disposed/sold 16,548 options to buy @ $14.3342, valued at $237.2k
Disposed/sold 9,432 options to buy @ $0.0017, valued at $16
Disposed/sold 34,416 options to buy @ $0.0017, valued at $58.5
Disposed/sold 22,464 options to buy @ $0.0017, valued at $38.2
05/05/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/05/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/05/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/05/2021 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
05/05/2021 8-K Quarterly results
05/05/2021 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
04/30/2021 10-Q Quarterly Report for the period ended March 31, 2021
04/30/2021 10-K/A Annual Report for the period ended December 31, 2020 [amend]
04/28/2021 GN GW Pharmaceuticals recognised for leadership in prescription cannabis-based medicines with prestigious Queen's Award for Enterprise in Innovation
04/23/2021 8-K Quarterly results
04/23/2021 GN GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals
04/20/2021 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/20/2021 8-K Quarterly results
04/20/2021 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
04/20/2021 GN GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complex
04/14/2021 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/14/2021 8-K Quarterly results
04/08/2021 4 Snyder Douglas B. (Chief Legal Officer) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns: Sold 8,400 shares @ $18.12, valued at $152.2k
03/30/2021 4 Knappertz Volker (Director) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns: Sold 3,060 shares @ $18.1, valued at $55.4k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy